A recent study in a genetic mouse model with primary podocyte injury leading to a CKD-mineral bone disease-like phenotype shows that although serum levels of phosphate and FGF23 were elevated, mice showed no signs of pathologic cardiac remodeling (197). This evidence concerns the gene FGF23 and chronic kidney disease.